S2014 Derm By Picture

Front 1

Back 1

Superficial spreading melanoma. 

Most common type of melanoma -

asymmetry, border irregularity, color variegation (black, blue, brown, pink, and white),

a diameter >6 mm, and a history of change (e.g., an increase in size or development of associated symptoms such as pruritus or pain)

Front 2

Back 2

Atopic Dermatitis

Environmental
- avoidance of irritants/allergens
- Temperature dec
- Humidity inc
- Avoid spec food
- Dust mite mitigation
- Stress reduction
Hydration
- Oitments, bathing less freq
Moisturizers and occlusive
- Avoid preservatives/frangrences
- Ointments/creams/lotions/solutions
Steroids
- Use least potency
- Non-fluoridated
Topical calcineurin inhibitors
Tar preparations
- Shampoo/bath additives
Wet dressings
- Used with topical corticosterioids in severe cases to hydrate and reduce scratching
Antibiotics
Antipruritic meds
- Avoid topical
Methoxypsoralen with UVA (derm)
Immunosuppressive therapy (derm)!

Front 3

Back 3

Subacute Atopic Dermatitis

Environmental
- avoidance of irritants/allergens
- Temperature dec
- Humidity inc
- Avoid spec food
- Dust mite mitigation
- Stress reduction
Hydration
- Oitments, bathing less freq
Moisturizers and occlusive
- Avoid preservatives/frangrences
- Ointments/creams/lotions/solutions
Steroids
- Use least potency
- Non-fluoridated
Topical calcineurin inhibitors
Tar preparations
- Shampoo/bath additives
Wet dressings
- Used with topical corticosterioids in severe cases to hydrate and reduce scratching
Antibiotics
Antipruritic meds
- Avoid topical
Methoxypsoralen with UVA (derm)
Immunosuppressive therapy (derm)!

Front 4

Back 4

Chronic Atopic Dermatitis

Environmental
- avoidance of irritants/allergens
- Temperature dec
- Humidity inc
- Avoid spec food
- Dust mite mitigation
- Stress reduction
Hydration
- Oitments, bathing less freq
Moisturizers and occlusive
- Avoid preservatives/frangrences
- Ointments/creams/lotions/solutions
Steroids
- Use least potency
- Non-fluoridated
Topical calcineurin inhibitors
Tar preparations
- Shampoo/bath additives
Wet dressings
- Used with topical corticosterioids in severe cases to hydrate and reduce scratching
Antibiotics
Antipruritic meds
- Avoid topical
Methoxypsoralen with UVA (derm)
Immunosuppressive therapy (derm)!

Front 5

Back 5

Seborrheic dermatitis

Low potency topical steroids + topical antifungal

Dandruff shampoos – leave in place 3-5 minutes

High potency topical steroid solutions- but limited use for severe scalp involvement

Front 6

Back 6

Seborrheic dermatitis

Cradle cap, goes away but comes back at puberty

T:
Hydration and occasional steroids

Front 7

Back 7

Lichen simplex chronicus




T:
Break cycle of chronic itching and scratching

High pot glucocorticoids
(pos under occlusion)

Oral antihistamines or tricyclic antidepressents with antihistaminic activity (sedation useful for pruritic)

Concerns: drowsiness with work/driving

Front 8

Back 8

Nummular (Discoid) Eczema

TEnvironmental
- avoidance of irritants/allergens
- Temperature dec
- Humidity inc
- Avoid spec food
- Dust mite mitigation
- Stress reduction
Hydration
- Oitments, bathing less freq
Moisturizers and occlusive
- Avoid preservatives/frangrences
- Ointments/creams/lotions/solutions
Steroids
- Use least potency
- Non-fluoridated
Topical calcineurin inhibitors
Tar preparations
- Shampoo/bath additives
Wet dressings
- Used with topical corticosterioids in severe cases to hydrate and reduce scratching
Antibiotics
Antipruritic meds
- Avoid topical
Methoxypsoralen with UVA (derm)
Immunosuppressive therapy (derm)

Front 9

Back 9

Xerotic Asteatotic eczema
Winter itch

T:
Topical moisturizers
Avoiding cutaneous irritants
Less bathing, harsh soaps

Front 10

Back 10

Keratosis pilaris

T:
Moisturizers, keratiniolytics

Front 11

Back 11

Irritant contact dermatitis

T:
Avoid irritants,
Wear protective gloves, clothing
High-portency topical steroids – relieve symptoms while dermatitis runs course

Removal and hydrate

Daily oral prednisone – tapered over 2-3 weeks

Front 12

Back 12

Allergic Contact Dermatitis

T:
High-portency topical steroids – relieve symptoms while dermatitis runs course

Removal and hydrate

Daily oral prednisone – tapered over 2-3 weeks

Front 13

Back 13

Dishydrosis/
Dishydrotic eczema

T:
1. Cold compresses
2. High dose topical corticosteroids
3. Calcineurin inhibitors
4. Oral corticosteroids
5. Systemic immunosuppressive agents
6. Botulism toxin A intradermal
7. Psoralen and subsequent exposure to long-wavelength UV light (PUVA)
8. Low nickel/cobalt diets or systemic chelators

Front 14

Back 14

Statis Dermatitis

T:
- - Leg elevation
- Compression stockings 30-40mmHg
- Emollients and/or mid-potency topical steroids and avoidance of irritants
- No scratching/damage to skin
- Diuretics

Steroids can be used on lesions but NOT on ulcer

Front 15

Back 15

Miliaria Diaper Rash

T:
1. Airing of diaper area
2. Frequent changes
3. Barrier ointments
4. Non-fluorinated, low pot corticosteroid ointment (<2 weeks)
5. Antifungals – consider Rx
6. Antibacterials for suspected bacterial
BE AWARE OF ABUSE (BURNS)

Front 16

Back 16

Intertrigo Diaper Rash

T:
1. Airing of diaper area
2. Frequent changes
3. Barrier ointments
4. Non-fluorinated, low pot corticosteroid ointment (<2 weeks)
5. Antifungals – consider Rx
6. Antibacterials for suspected bacterial
BE AWARE OF ABUSE (BURNS)

Front 17

Back 17

Contact derm Diaper Rash

May not see in folds of skin – where urine does not sit directly on skin from diaper

T:
1. Airing of diaper area
2. Frequent changes
3. Barrier ointments
4. Non-fluorinated, low pot steroid ointment (<2 weeks)
5. Antifungals – consider Rx
6. Antibacterials for suspected bacterial
BE AWARE OF ABUSE (BURNS)

Front 18

Back 18

Candidal Diaper Rash

Does not present in folds
mouth (thrush)

Use of antibiotics increases colonization

T:
1. Airing of diaper area
2. Frequent changes
3. Barrier ointments
5. Antifungals – consider Rx
BE AWARE OF ABUSE (BURNS)

Front 19

Back 19

Bacterial Diaper Dermatitis

Callous impetigo
Folliculitis
Cellulitis


Open wounds where skin has atrophied

Bullous impetigo or folliculitis (s. aureus), cellulitis (strep)

Tests:
Polymicrobial growth in rash >50%

Also contain anerobes

Front 20

Back 20

Seborrheic diaper dermatitis

Associated with cradle cap

T:
- Hydration
- Occasionally steroid creams
BE AWARE OF ABUSE (BURNS)

Front 21

Back 21

Atopic eczema

- Hydration
BE AWARE OF ABUSE (BURNS)

Front 22

Back 22

Granuloma gluteal infantum

T:
7. Airing of diaper area
8. Frequent changes
9. Barrier ointments
10. Non-fluorinated, low pot corticosteroid ointment (<2 weeks)
11. Antifungals – consider Rx
12. Antibacterials for suspected bacterial
BE AWARE OF ABUSE (BURNS)

Front 23

Back 23

Plaque-type (discoid) psoriasis

T:
- avoid excess drying or irritation of skin

Localized, plaque type:
- mid-potency topical
- topical vit D (calcipotriene)
- Retinoid (tazarotene)
- coal tar, salicylic acid, anthralin

Mild/Moderate widespread:
- UV light w/ oral/topical psoralens &sunscreen

Severe widespread:
- methotrexate (antimetabolite) - esp. for psoriatic arthritis)
- acitretin (retinoid)
- cyclosporine (calcineurin inhibitor)
Immunoregulation:
- cyclosporine & other immunosuppressives
suppressive agents
- Biologic agents with more selective immunosuppressive properties and better safety profiles
a. TNF inhibitors may worsen CHF
b. Non-immunosuppressive agents should be initatd if severe infection
c. Routine screening for TB, reactivation risk
d. Progressive multifocal leukoencephalopathy seen in association with treat with TNF-inhibitors
e. Malignancies, may limit use

Drugs – alefacept, etanercept, adalimumab, infliximab

Front 24

Back 24

Inverse psoriasis

T:
- avoid excess drying or irritation of skin

Localized, plaque type:
- mid-potency topical
- topical vit D (calcipotriene)
- Retinoid (tazarotene)
- coal tar, salicylic acid, anthralin

Mild/Moderate widespread:
- UV light w/ oral/topical psoralens &sunscreen

Severe widespread:
- methotrexate (antimetabolite) - esp. for psoriatic arthritis)
- acitretin (retinoid)
- cyclosporine (calcineurin inhibitor)
Immunoregulation:
- cyclosporine & other immunosuppressives
suppressive agents
- Biologic agents with more selective immunosuppressive properties and better safety profiles
a. TNF inhibitors may worsen CHF
b. Non-immunosuppressive agents should be initatd if severe infection
c. Routine screening for TB, reactivation risk
d. Progressive multifocal leukoencephalopathy seen in association with treat with TNF-inhibitors
e. Malignancies, may limit use

Drugs – alefacept, etanercept, adalimumab, infliximab

Front 25

Back 25

Guttate psoriasis

T:
- avoid excess drying or irritation of skin

Localized, plaque type:
- mid-potency topical
- topical vit D (calcipotriene)
- Retinoid (tazarotene)
- coal tar, salicylic acid, anthralin

Mild/Moderate widespread:
- UV light w/ oral/topical psoralens &sunscreen

Severe widespread:
- methotrexate (antimetabolite) - esp. for psoriatic arthritis)
- acitretin (retinoid)
- cyclosporine (calcineurin inhibitor)
Immunoregulation:
- cyclosporine & other immunosuppressives
suppressive agents
- Biologic agents with more selective immunosuppressive properties and better safety profiles
a. TNF inhibitors may worsen CHF
b. Non-immunosuppressive agents should be initatd if severe infection
c. Routine screening for TB, reactivation risk
d. Progressive multifocal leukoencephalopathy seen in association with treat with TNF-inhibitors
e. Malignancies, may limit use

Drugs – alefacept, etanercept, adalimumab, infliximab

Front 26

Back 26

pustular psoriasis


T:T:
- avoid excess drying or irritation of skin

Localized, plaque type:
- mid-potency topical
- topical vit D (calcipotriene)
- Retinoid (tazarotene)
- coal tar, salicylic acid, anthralin

Mild/Moderate widespread:
- UV light w/ oral/topical psoralens &sunscreen

Severe widespread:
- methotrexate (antimetabolite) - esp. for psoriatic arthritis)
- acitretin (retinoid)
- cyclosporine (calcineurin inhibitor)
Immunoregulation:
- cyclosporine & other immunosuppressives
suppressive agents
- Biologic agents with more selective immunosuppressive properties and better safety profiles
a. TNF inhibitors may worsen CHF
b. Non-immunosuppressive agents should be initatd if severe infection
c. Routine screening for TB, reactivation risk
d. Progressive multifocal leukoencephalopathy seen in association with treat with TNF-inhibitors
e. Malignancies, may limit use

Drugs – alefacept, etanercept, adalimumab, infliximab

Front 27

Back 27

erythrodermic psoriasis (severe pustular)

T:
oral retinoids in non-pregnant Pts

Front 28

Back 28

Nail psoriasis

T:
- avoid excess drying or irritation of skin

Localized, plaque type:
- mid-potency topical
- topical vit D (calcipotriene)
- Retinoid (tazarotene)
- coal tar, salicylic acid, anthralin

Mild/Moderate widespread:
- UV light w/ oral/topical psoralens &sunscreen

Severe widespread:
- methotrexate (antimetabolite) - esp. for psoriatic arthritis)
- acitretin (retinoid)
- cyclosporine (calcineurin inhibitor)
Immunoregulation:
- cyclosporine & other immunosuppressives
suppressive agents
- Biologic agents with more selective immunosuppressive properties and better safety profiles
a. TNF inhibitors may worsen CHF
b. Non-immunosuppressive agents should be initatd if severe infection
c. Routine screening for TB, reactivation risk
d. Progressive multifocal leukoencephalopathy seen in association with treat with TNF-inhibitors
e. Malignancies, may limit use

Drugs – alefacept, etanercept, adalimumab, infliximab

Front 29

Back 29

psoriatic arthritis

•Usually hands & feet, occasionally large joints
•Stiffness, pain & progressive joint damage

T:T:
- avoid excess drying or irritation of skin

Localized, plaque type:
- mid-potency topical
- topical vit D (calcipotriene)
- Retinoid (tazarotene)
- coal tar, salicylic acid, anthralin

Mild/Moderate widespread:
- UV light w/ oral/topical psoralens &sunscreen

Severe widespread:
- methotrexate (antimetabolite) - esp. for psoriatic arthritis)
- acitretin (retinoid)
- cyclosporine (calcineurin inhibitor)
Immunoregulation:
- cyclosporine & other immunosuppressives
suppressive agents
- Biologic agents with more selective immunosuppressive properties and better safety profiles
a. TNF inhibitors may worsen CHF
b. Non-immunosuppressive agents should be initatd if severe infection
c. Routine screening for TB, reactivation risk
d. Progressive multifocal leukoencephalopathy seen in association with treat with TNF-inhibitors
e. Malignancies, may limit use

Drugs – alefacept, etanercept, adalimumab, infliximab

Front 30

Back 30

Oral psoriasis

T:
- avoid excess drying or irritation of skin

Localized, plaque type:
- mid-potency topical
- topical vit D (calcipotriene)
- Retinoid (tazarotene)
- coal tar, salicylic acid, anthralin

Mild/Moderate widespread:
- UV light w/ oral/topical psoralens &sunscreen

Severe widespread:
- methotrexate (antimetabolite) - esp. for psoriatic arthritis)
- acitretin (retinoid)
- cyclosporine (calcineurin inhibitor)
Immunoregulation:
- cyclosporine & other immunosuppressives
suppressive agents
- Biologic agents with more selective immunosuppressive properties and better safety profiles
a. TNF inhibitors may worsen CHF
b. Non-immunosuppressive agents should be initatd if severe infection
c. Routine screening for TB, reactivation risk
d. Progressive multifocal leukoencephalopathy seen in association with treat with TNF-inhibitors
e. Malignancies, may limit use

Drugs – alefacept, etanercept, adalimumab, infliximab

Front 31

Back 31

Lichen Planus

T:
Clinical course variable, most have spontaneous remissionin 6 mos to 2 yrs

•Topical glucocorticoids

Front 32

Back 32

Pityriasis Rosea

T:
Relief of pruritus is the primary goal of Rx
-mid-potency topical corticosteroids
-oral histamine
-sunlight
-high-dose acyclovir may shorten duration if given early
Warning: Don’t tan after rash is gone!

Front 33

Back 33

Erythema Multiforme Minor

- Symptomatic treatment
- oral antihistamines, analgesics, local skin care, magic mouthwash
- hydration
- if drug induced, withdraw ALL drugs
- consult

Front 34

Back 34

Erythema multiforme major

T:
Symptomatic treatment most important; most cases are self limited (oral antihistamines, analgesics, local skin care, and soothing mouthwashes)

•More severe cases -meticulous wound care & Burrow or Domeborosolution dressings

•Hydration/monitor fluid status for extensive skin involvement (essentially 66-75% fluid resuscitation for similar size burn)

Drug suspected
–Withdraw drug, reduce risk of death by ~30% /day with prompt withdrawal (including all meds started in the preceding 2 months)

–Discontinue all unnecessary medications
•Infections treated after cultures and/or serologic tests and antiseptics to avoid super infection (espgenitals)

•Conjunctival inflammation –topical lubricants for dry eyes, sweeping of conjunctival fornices, and removal of fresh adhesions

•HSV-associated EM –antiviral suppression considered for prevention (herpes), Rx started after the eruption of EM has no effect on course

Front 35

Back 35

Stevens Johnson Syndrome and toxic epidermal necrolysis

T: *Treat like burn patient
-w/draw offending agent
-fluid management
-topical analgesics & washes of mucositis
-tetanus status (lock-jaw)
-plasmapheresis, immunosuppressive therapy, IVIG

Front 36

Back 36

bullous pemphigoid

Tests: DIF/TDIF

Treatment:
- reduce inflammation
-anti-inflammatory agents:
-corticosteroids (high doses)
-tetracyclines
-dapsone
-immunosuppressant drugs:
-azathioprine
-methotrexate
-mycophenolate mofetil
-cyclophosphamide
-anti-CD20 antibody: targets antibody-producing B cells

Front 37

Back 37

ACNE VULGARIS

Treatment
face washing
non-comedogenic make-up
benzoyl peroxide
Topical antibiotics
Topical retinoids
Systemic antibiotics
Systemic anti-inflammitory
oral contraceptives
sprionolactone (binds the androgen receptor)

Front 38

Back 38

Papulopustular Drug Reactions

Front 39

Back 39

Eruptive Vellus hair cysts

T: incision and drainage (scarring)
CO2 laser (hard on large areas)
topical retinoids and 12% lactic acid preparations

Front 40

Back 40

steroid acne

T: resolves at stop of steroid use
also can treat like acne vulgaris

Front 41

Back 41

Chloracne

T: stop exposure

Front 42

Back 42

Secondary syphilis (‘great pox’)

Front 43

Back 43

Erythematotelangiectatic type (ETR)

Front 44

Back 44

Papulopustular rosacea (PPR)

Front 45

Back 45

Phymatous rosacea

Front 46

Back 46

Hidradenitis suppurativa

Front 47

Back 47

Hidradenitis suppurativa

Front 48

Back 48

Hidradenitis suppurativa

Front 49

Back 49

Hidradenitis suppurativa

Front 50

Back 50

Perioral Dermatitis

Front 51

Back 51

Perioral Dermatitis

Front 52

Back 52

Perioral Dermatitis

Front 53

Back 53

Ocular rosacea

Front 54

Back 54

Papulopustular rosacea (PPR)

Front 55

Back 55

Generalized cutaneous candidiasis

Front 56

Back 56

Intertrigo

Front 57

Back 57

Paronychia

Front 58

Back 58

onychomycosis

Front 59

Back 59

Tinea corporis

Front 60

Back 60

Tinea capitis

Front 61

Back 61

Tinea corporis

Front 62

Back 62

tinea pedis

Front 63

Back 63

Tinea cruris

Front 64

Back 64

Tinea manuum

Front 65

Back 65

Tinea barbae

Front 66

Back 66

Tinea faciale

Front 67

Back 67

Tinea unguium (onychomycosis)

Front 68

Back 68

Tinea unguium (onychomycosis)

Front 69

Back 69

Kerion

Front 70

Back 70

Dermatophytosis

Front 71

Back 71

Lupoid sycosis/sycosis barbae (barber itch)

Front 72

Back 72

Tinea versicolor (Pityriasis versicolor)

Front 73

Back 73

Tinea versicolor (Pityriasis versicolor)

Front 74

Back 74

Onychomycosis
Distal lateral subungual

Front 75

Back 75

White superficial onychomycosis-

Front 76

Back 76

Total dystrophic onychomycosis-

Front 77

Back 77

Candida onychomycosis-

Front 78

Back 78

onychomycosis

"aurora borealis"

Front 79

Back 79

Telogen effluvium

Front 80

Back 80

Telogen Effluvium

Front 81

Back 81

Telogen Effluvium

Front 82

Back 82

Androgenetic alopecia

Front 83

Back 83

Alopecia areata

Front 84

Back 84

Ophiasis

Front 85

Back 85

Sisaipho

Front 86

Back 86

Sisaipho

Front 87

Back 87

Alopecia totalis

Front 88

Back 88

Alopecia universalis

Front 89

Back 89

Alopecia areata

Front 90

Back 90

Paronychia

Felon

Front 91

Back 91

Paronychia

Front 92

Back 92

Paronychia

Front 93

Back 93

Vitiligo

Front 94

Back 94

Vitiligo

Front 95

Back 95

Localized vitiligo
Focal:

Front 96

Back 96

Segmental

patches of white hair (poliosis - lacks melanin);

Front 97

Back 97

Generalized vitiligo
Acrofacial

Front 98

Back 98

Universal vitiligo

Front 99

Back 99

Melasma

Front 100

Back 100

Melasma

Front 101

Back 101

Postinflammatory Hyper/hypopigmentation

Front 102

Back 102

Angioedema

Front 103

Back 103

Angioedema

Front 104

Back 104

Urticaria

Front 105

Back 105

Infectious
urticaria

Front 106

Back 106

Cold-induced urticaria – dominant heritance

Front 107

Back 107

Solar urticaria

Front 108

Back 108

Cholinergic urticaria

Front 109

Back 109

Dermatographism

Front 110

Back 110

Drug Rashes
Antibiotics

Front 111

Back 111

Drug Rashes
Maculopapular rash from PCN or ampicillin

Front 112

Back 112

Insect Allergy

Front 113

Back 113

Insect Allergy

Front 114

Back 114

Insect Allergy

Front 115

Back 115

Burn

Front 116

Back 116

Burn 2nd

Front 117

Back 117

Burn 2nd

Front 118

Back 118

Burn 3rd

Front 119

Back 119

Pressure Ulcers

Front 120

Back 120

Acanthosis nigricans

Front 121

Back 121

Acanthosis nigricans

Acrochordons

Front 122

Back 122

Acanthosis nigricans

Front 123

Back 123

Lipomas/epithelial inclusion cysts

Front 124

Back 124

Lipomas/epithelial inclusion cysts

Front 125

Back 125

Lipomas/epithelial inclusion cysts

Front 126

Back 126

Lipomas/epithelial inclusion cysts

Front 127

Back 127

Lipomas/epithelial inclusion cysts

Front 128

Back 128

Lipomas/epithelial inclusion cysts

Front 129

Back 129

Lipomas/epithelial inclusion cysts

Front 130

Back 130

Epidermoid Cysts

Front 131

Back 131

Epidermoid Cysts

Front 132

Back 132

Epidermoid Cysts

Front 133

Back 133

Epidermoid Cysts

Front 134

Back 134

Epidermoid Cysts

Front 135

Back 135

Pilonidal diseaseSacrococcygeal pilonidal sinusitis

Front 136

Back 136

Pilonidal diseaseSacrococcygeal pilonidal sinusitis

Front 137

Back 137

Pilonidal diseaseSacrococcygeal pilonidal sinusitis

Front 138

Back 138

Pilonidal diseaseSacrococcygeal pilonidal sinusitis

Front 139

Back 139

Pilonidal diseaseSacrococcygeal pilonidal sinusitis

Front 140

Back 140

Neurofibromatosis type 1 & 2

Front 141

Back 141

Neurofibromatosis type 1 & 2

Front 142

Back 142

Sturge-Weber syndrome (craniofacial or trigeminocranial angiomatosis w/ cerebral calcification)

Front 143

Back 143

Tuberous sclerosis (Borneville’s disease)

Front 144

Back 144

Ataxia-Telangiectasia (Louis-Bar disease)

Front 145

Back 145

Rendu-Osler-Weber syndrome (hereditary hemorrhagic telangiectasia - HHT)

Front 146

Back 146

Seborrheic keratosis

Front 147

Back 147

Seborrheic keratosis

Front 148

Back 148

Seborrheic keratosis

Front 149

Back 149

Seborrheic keratosis

Front 150

Back 150

Actinic keratosis

Front 151

Back 151

Actinic keratosis

Front 152

Back 152

Basal Cell Carcinoma

Front 153

Back 153

Basal Cell Carcinoma

Front 154

Back 154

Basal Cell Carcinoma

Front 155

Back 155

Squamous Cell Carcinoma

Front 156

Back 156

Squamous Cell Carcinoma

Front 157

Back 157

Squamous Cell Carcinoma

Front 158

Back 158

Squamous Cell Carcinoma

Front 159

Back 159

Melanoma

Front 160

Back 160

Superficial Spreading Melanoma

Front 161

Back 161

Nodular Melanoma

Front 162

Back 162

Lentigo maligna Melanoma

Front 163

Back 163

Acral lentiginous Melanoma

Front 164

Back 164

Acral (subungual) Melanoma

Front 165

Back 165

Xeroderma pigmentosa(XP)

Front 166

Back 166

Large Congenital Nevus

Front 167

Back 167

Kaposi sarcoma

Front 168

Back 168

Kaposi sarcoma

Front 169

Back 169

Kaposi sarcoma

Front 170

Back 170

Cellulitis

Front 171

Back 171

Cellulitis

Front 172

Back 172

Cellulitis

Front 173

Back 173

Cellulitis

Front 174

Back 174

Cellulitis

Front 175

Back 175

Erysipelas

Front 176

Back 176

Erysipelas

Front 177

Back 177

Nonbullous impetigo

Front 178

Back 178

Bullous impetigo

Front 179

Back 179

Impetigo

Front 180

Back 180

Lice

Front 181

Back 181

Lice

Front 182

Back 182

Scabies

Front 183

Back 183

Scabies

Front 184

Back 184

Scabies

Front 185

Back 185

Brown Recluse Spider

Front 186

Back 186

Brown Recluse Spider

Front 187

Back 187

Brown Recluse Spider

Front 188

Back 188

Measles

Front 189

Back 189

Measles

Front 190

Back 190

Measles

Front 191

Back 191

Measles

Front 192

Back 192

Measles

Front 193

Back 193

Strep pharyngitisScarlet fever

Front 194

Back 194

Strep pharyngitisScarlet fever

Front 195

Back 195

Strep pharyngitisScarlet fever

Front 196

Back 196

Strep pharyngitisScarlet fever

Front 197

Back 197

Strep pharyngitisScarlet fever

Front 198

Back 198

Rubella

Front 199

Back 199

Rubella

Front 200

Back 200

Rubella

Front 201

Back 201

Congenital Rubella Syndrome

Front 202

Back 202

Congenital Rubella Syndrome

Front 203

Back 203

Erythema Infectiosum

Front 204

Back 204

Erythema Infectiosum

Front 205

Back 205

Erythema Infectiosum
Fetal hydops

Front 206

Back 206

Erythema Infectiosum
Fetal hydops

Front 207

Back 207

Roseola

Front 208

Back 208

Roseola

Front 209

Back 209

Varicella

Front 210

Back 210

Varicella

Front 211

Back 211

In utero VZV infection

Front 212

Back 212

Varicella

Front 213

Back 213

Varicella

Front 214

Back 214

Varicella

Front 215

Back 215

Varicella Zoster

Front 216

Back 216

Varicella Zoster

Front 217

Back 217

Nongenital cutaneous HPV

Front 218

Back 218

Palmoplantar warts
HPV

Front 219

Back 219

Epidermodysplasia verruciformis (EV) HPV

Front 220

Back 220

Flat warts HPV

Front 221

Back 221

Verrucae HPV

Front 222

Back 222

Verrucae HPV

Front 223

Back 223

Verrucae HPV

Front 224

Back 224

Verrucae HPV

Front 225

Back 225

Verrucae HPV

Front 226

Back 226

Anogenital HPV

Front 227

Back 227

Anogenital HPV

Front 228

Back 228

Laryngeal Papillomatosis

Front 229

Back 229

Laryngeal Papillomatosis

Front 230

Back 230

HPV
cervical dysplasia

Front 231

Back 231

Molluscum contagiosum

Front 232

Back 232

Molluscum contagiosum

Front 233

Back 233

Molluscum contagiosum

Front 234

Back 234

Molluscum contagiosum

Front 235

Back 235

HSV - Gingivostomatitis

Front 236

Back 236

HSV - Gingivostomatitis

Front 237

Back 237

HSV - Gingivostomatitis

Front 238

Back 238

HSV – Acute Herpetic Pharyngotonsillitis

Front 239

Back 239

HSV – Acute Herpetic Labialis

Front 240

Back 240

HSV – Primary Genital Herpes

Front 241

Back 241

HSV – Primary Genital Herpes

Front 242

Back 242

Eczema herpeticum underlying dermatitis

HSV

Front 243

Back 243

Herpetic whitlow